Clinical benefit of Hylan GF-20 over conventional therapy at similar cost in knee OA
Prospective randomized study comparing the medicoeconomic benefits of Hylan GF-20 vs. conventional treatment in knee osteoarthritisJoint Bone Spine. 2003 Aug;70(4):276-81
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
506 patients with knee osteoarthritis and failed response to pharmacological intervention were randomized to receive either three weekly intra-articular injections of Hylan G-F 20 (Synvisc) or conventional therapy. The purpose of the study was to compare the clinical efficacy of the two treatment regimens over a span of 9 months, as well as to evaluate economic factors associated with Hylan G-F 20...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE